Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-17 Sale |
2021-11-19 3:34 pm |
Trillium Therapeutics Inc. | TRIL | Walker Paul Edward Director |
5,736,363 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2021-11-17 Sale |
2021-11-19 1:30 pm |
Trillium Therapeutics Inc. | TRIL | Harrison Rosemary See Remarks |
75 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-07 Sale |
2021-07-09 4:30 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $9 | $32,814 | 102,083 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 4:23 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $8.27 | $30,152 | 105,729 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:12 pm |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
130,500 | $9.2083 | $1,201,683 | 1,580,302 (Direct) |
View |
| 2021-05-07 Sale |
2021-05-11 4:24 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $9.3 | $33,908 | 109,375 (Direct) |
View |
| 2021-04-07 Sale |
2021-04-09 5:38 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $10.82 | $39,450 | 113,021 (Direct) |
View |
| 2021-04-08 Sale |
2021-04-09 5:23 pm |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
5,312 | $11.09 | $58,910 | 133,440 (Direct) |
View |
| 2021-03-12 Sale |
2021-03-15 5:12 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
2,917 | $11.97 | $34,916 | 58,333 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-12 4:40 pm |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
5,312 | $11.08 | $58,857 | 138,752 (Direct) |
View |
| 2021-03-08 Sale |
2021-03-10 5:57 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $10.11 | $36,861 | 116,667 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-10 7:18 pm |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
5,820 | $12.78 | $74,397 | 148,638 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-10 7:18 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
7,147 | $12.77 | $91,270 | 186,823 (Direct) |
View |
| 2021-01-13 Sale |
2021-01-15 4:19 pm |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
25,000 | $15.03 | $375,787 | 2,519,581 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-13 4:12 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
584 | $15.2 | $8,879 | 5,844 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-13 4:11 pm |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
508 | $15.21 | $7,725 | 5,082 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 4:12 pm |
Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer |
8,505 | $15.79 | $134,271 | 5,761 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 4:11 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
8,517 | $15.71 | $133,806 | 87,640 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 4:10 pm |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,604 | $15.5 | $40,365 | 57,292 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-11 4:19 pm |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,708 | $14.71 | $39,843 | 92,084 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-11 4:17 pm |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $14.75 | $53,782 | 123,959 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-07 Exercise |
2021-07-09 4:30 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0 | 102,083 (Direct) |
View |
| 2021-07-07 Exercise |
2021-07-09 4:30 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0.3039 | 102,083 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 4:35 pm |
N/A 2031-07-01 |
Trillium Therapeutics Inc. | TRIL | MACKEY CATHERINE J Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 4:23 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0 | 105,729 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 4:23 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0.315 | 105,729 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:12 pm |
N/A 2029-09-25 |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
130,500 | $0 | 1,580,302 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:12 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
87,500 | $0.4462 | 1,580,302 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:12 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
43,000 | $0.314 | 1,580,302 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-11 4:24 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0 | 109,375 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-11 4:24 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0.313 | 109,375 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 4:17 pm |
N/A 2031-05-03 |
Trillium Therapeutics Inc. | TRIL | Looker Benjamin General Counsel |
190,000 | $0 | 190,000 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 4:16 pm |
N/A 2031-05-03 |
Trillium Therapeutics Inc. | TRIL | Myers Scott Dunseth Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 5:38 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0 | 113,021 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 5:38 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0.3012 | 113,021 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-09 5:23 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,708 | $0.3022 | 133,440 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-09 5:23 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
5,312 | $0 | 133,440 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-09 5:23 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,604 | $3.3638 | 133,440 (Direct) |
View |
| 2021-03-12 Exercise |
2021-03-15 5:12 pm |
N/A 2028-11-08 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
2,917 | $0 | 58,333 (Direct) |
View |
| 2021-03-12 Exercise |
2021-03-15 5:12 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
2,917 | $3.3924 | 58,333 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 4:40 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
5,312 | $0 | 138,752 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 4:40 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,604 | $3.3524 | 138,752 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 4:40 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,708 | $0.3012 | 138,752 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-10 5:57 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0 | 116,667 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-10 5:57 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0.2999 | 116,667 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:18 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
5,820 | $0 | 148,638 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:18 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,708 | $0.2977 | 148,638 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-10 7:18 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
508 | $9.6213 | 148,638 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:18 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,604 | $3.3137 | 148,638 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:18 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
7,147 | $0 | 186,823 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:18 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0.2977 | 186,823 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-10 7:18 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
584 | $9.6213 | 186,823 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:18 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
2,917 | $3.3137 | 186,823 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:19 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
5,419 | $0.4248 | 2,519,581 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:19 pm |
N/A 2029-09-25 |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
25,000 | $0 | 2,519,581 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-15 4:19 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
19,581 | $0.4275 | 2,519,581 (Direct) |
View |
| 2021-01-11 Exercise |
2021-01-13 4:12 pm |
N/A 2027-11-09 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
584 | $0 | 5,844 (Direct) |
View |
| 2021-01-11 Exercise |
2021-01-13 4:12 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
584 | $9.5671 | 5,844 (Direct) |
View |
| 2021-01-11 Exercise |
2021-01-13 4:11 pm |
N/A 2027-11-09 |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
508 | $0 | 5,082 (Direct) |
View |
| 2021-01-11 Exercise |
2021-01-13 4:11 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
508 | $9.5671 | 5,082 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:12 pm |
N/A 2026-11-09 |
Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer |
8,505 | $0 | 5,761 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:12 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer |
8,505 | $7.2447 | 5,761 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:11 pm |
N/A 2026-05-27 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
8,517 | $0 | 87,640 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:11 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
5,600 | $11.01 | 87,640 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:11 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
2,917 | $3.331 | 87,640 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:10 pm |
N/A 2028-11-08 |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,604 | $0 | 57,292 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:10 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,604 | $3.331 | 57,292 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 4:19 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,708 | $0 | 92,084 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 4:19 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Petrova Penka Chief Development Officer |
2,708 | $0.2987 | 92,084 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 4:17 pm |
N/A 2029-11-07 |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0 | 123,959 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 4:17 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer |
3,646 | $0.2987 | 123,959 (Direct) |
View |
Ownership |
2021-01-04 8:22 pm |
N/A 2030-11-15 |
Trillium Therapeutics Inc. | TRIL | Pucci Paolo Director |
0 | $0 | 67,000 (Direct) |
View |